Education And Academic Experience：
1. 1997 – 2001 Sichuan University, Bachelor
2. 2001 – 2006 Sichuan University, Doctor of Philosophy
3. 2008 – 2010 National Center for Toxicological Research, U.S. FDA, Post-doctor Research.
Publications:
1、Zhining Wen, Yu Liang, Yingyi Hao, Brian Delavan, Ruili Huang, Mike Mikailov, Weida Tong, Menglong Li*, and Zhichao Liu*, Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management. Drug Discovery Today, 2019, 24: 9-15.
2、Yuan Liu, Runyu Jing, Zhining Wen* and Menglong Li*, Narrowing the Gap Between In Vitro and In Vivo Genetic Profiles by Deconvoluting Toxicogenomic Data In Silico. Frontiers in Pharmacology, 2020, 10: 1489.
3、Yiru Zhao, Yifan Zhou, Yuan Liu, Yinyi Hao, Menglong Li, Xuemei Pu, Chuan Li* and Zhining Wen*, Uncovering the prognostic gene signatures for the improvement of risk stratification in cancers by using deep learning algorithm coupled with wavelet transform. BMC Bioinformatics, 2020, 21: 195.
4、Yuanli Zuo, Yu Liang, Jiting Zhang, Yingyi Hao, Menglong Li, Zhining Wen* and Yun Zhao*, Transcriptome Analysis Identifies Piwi-Interacting RNAs as Prognostic Markers for Recurrence of Prostate Cancer. Frontiers in Genetics, 2019, 10: 1018.
5、Yu Liang, Li He, Yiru Zhao, Yinyi Hao, Yifan Zhou, Menglong Li, Chuan Li, Xuemei Pu* and Zhining Wen*, Comparative Analysis for the Performance of Variant Calling Pipelines on Detecting the de novo Mutations in Humans. Frontiers in Pharmacology, 2019, 10: 358.
